Katsuya Tanaka

Katsuya Tanaka

Auto-generated profile, based on publicly available information

Katsuya Tanaka

Department of Anesthesiology, Tokushima University, Tokushima 770-8503, Japan

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2009 in Anesthesiology
Verified
Journal Article
Closed access
PDF file
KTKatsuya Tanaka
Katsuya Tanaka
TKTakashi Kawano
Takashi Kawano
TTTakehito Tomino
Takehito Tomino
HKHiroaki Kawano
Hiroaki Kawano
TOTsuyoshi Okada
Tsuyoshi Okada
YNYutaka Nakaya
Yutaka Nakaya
DIABETES and hyperglycemia are significant predictors of perioperative cardiovascular morbidity and mortality.1 Several studies1–4 have shown that there is a strong correlation between blood glucose concentration and outcome in patients with coronary artery disease. These studies have suggested that a decrease in blood glucose concentration results in a lower rate of cardiovascular morbidity and mortality. Volatile anesthetics have been shown to have cardioprotective5,6 and vasodilative7–9 effects, which are mediated by activation of adenosine triphosphate–sensitive potassium (KATP) channels in cardiac myocytes and vascular smooth muscle cells, respectively. Volatile anesthetics have been known since the 1970s to impair insulin secretion and glucose utilization.10–15 However, the precise mechanism of action responsible for impaired insulin secretion in response to volatile anesthetics remains unclear.

1 January 2011 in Life Sciences
Verified
Journal Article
Closed access
KTKatsuya Tanaka
Katsuya Tanaka
TKTakashi Kawano
Takashi Kawano
YTYasuo M. Tsutsumi
Yasuo M. Tsutsumi
MKMichiko Kinoshita
Michiko Kinoshita
NKNami Kakuta
Nami Kakuta
SOShuzo Oshita
Shuzo Oshita

1 April 2014 in Local and Regional Anesthesia
Verified
Journal Article
Open access
KTKatsuya Tanaka
Katsuya Tanaka
RKRyosuke Kawanishi
Ryosuke Kawanishi
YTYasuo M Tsutsumi
Yasuo M Tsutsumi
YTYoshitsugu Takeda
Yoshitsugu Takeda
KYKaori Yamamoto
Kaori Yamamoto
YTYoko Tobetto
Yoko Tobetto
Perineural but not systemic low-dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial Ryosuke Kawanishi,1 Kaori Yamamoto,2 Yoko Tobetto,2 Kayo Nomura,2 Michihisa Kato,2 Ritsuko Go,2 Yasuo M Tsutsumi,3 Katsuya Tanaka,3 Yoshitsugu Takeda4 1Department of Anesthesiology, Tokushima University Hospital, Tokushima, 2Division of Anesthesiology, Tokushima Red Cross Hospital, Komatsushima, 3Department of Anesthesiology, Institute of Health Bioscience, University of Tokushima Graduate School, Tokushima, 4Division of Orthopedics, Tokushima Red Cross Hospital, Komatsushima, Japan Purpose: To determine the effects of intravenous and perineural dexamethasone on the duration of interscalene brachial plexus block (ISB) with ropivacaine in patients undergoing arthroscopic shoulder surgery. Patients and methods: In this prospective, randomized, placebo-controlled trial, patients presenting for arthroscopic shoulder surgery with an ISB were randomized to receive ropivacaine 0.75% (group C), ropivacaine 0.75% plus perineural dexamethasone 4 mg (group Dperi), or ropivacaine 0.75% plus intravenous dexamethasone 4 mg (group Div). The primary outcome was the duration of analgesia, defined as the time between performance of the block and the first request for analgesic. Results: Thirty-nine patients were randomized. The median times of sensory block in groups C, Dperi, and Div were 11.2 hours (interquartile range [IQR] 8.0–15.0 hours), 18.0 hours (IQR 14.5–19.0 hours), and 14.0 hours (IQR 12.7–15.1 hours), respectively. Significant differences were observed between groups Dperi and C (P=0.001). Kaplan–Meier analysis for the first analgesic request showed significant differences between groups Dperi and C (P=0.005) and between groups Dperi and Div (P=0.008), but not between groups C and Div. Conclusion: Perineural but not intravenous administration of 4 mg of dexamethasone significantly prolongs the duration of effective postoperative analgesia resulting from a single-shot ISB with ropivacaine 0.75%. Keywords: ropivacaine, interscalene nerve block, dexamethasone, postoperative pain, perineural

20 June 2008 in International Journal of Computer Assisted Radiology and Surgery
Verified
Journal Article
Closed access
PDF file
Jumpei ArataJumpei Arata
Jumpei Arata
HTHiroki Takahashi
Hiroki Takahashi
SYShigen Yasunaka
Shigen Yasunaka
KOKazushi Onda
Kazushi Onda
KTKatsuya Tanaka
Katsuya Tanaka
MHMakoto Hashizume
Makoto Hashizume

1 May 2007 in Anesthesiology
Verified
Journal Article
Closed access
PDF file
KTKatsuya Tanaka
Katsuya Tanaka
Takashi KawanoTakashi Kawano
Takashi Kawano
ANAkiyo Nakamura
Akiyo Nakamura
HNHossein Nazari
Hossein Nazari
SKShinji Kawahito
Shinji Kawahito
YNYutaka Nakaya
Yutaka Nakaya
ADENOSINE triphosphate-sensitive potassium (KATP) channels are present in both cardiomyocytes and vascular smooth muscle cells (VSMCs).1 The cardiac KATPchannel is composed of a sulfonylurea receptor (SUR) 2A and an inwardly rectifying K+channel subunit (Kir) 6.2, whereas the vascular KATPchannel seems to be a complex of SUR2B and Kir6.1.1,2 Different combinations of Kir6.x and SUR.x yield tissue-specific KATPchannel subtypes with different features and distinct functional properties.3 We previously reported that there were tissue-specific effects of either local or intravenous anesthetics on KATPchannels, and that they had different effects on KATPchannels in different tissures.4–6

20 August 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AMAyumu Matsumoto
Ayumu Matsumoto
SSShiho Satomi
Shiho Satomi
NKNami Kakuta
Nami Kakuta
SNSoshi Narasaki
Soshi Narasaki
YTYukari Toyota
Yukari Toyota
Yasuo TsutsumiYasuo Tsutsumi
Yasuo Tsutsumi
(1) Background: Remimazolam is a novel benzodiazepine that prevents postoperative nausea and vomiting (PONV), is more effective than volatile anesthetics, and was recently approved for use in Japan. (2) Methods: This prospective, double-blind, randomized controlled trial study aimed to compare the efficacy of remimazolam and propofol as general anesthetics in terms of the incidence of PONV after laparoscopic gynecological surgery (UMIN000046237). High-risk female patients who underwent general anesthesia with either remimazolam or propofol for the maintenance of anesthesia were enrolled. The primary outcome was the incidence of PONV in the two groups (i.e., REM versus PROP) 2 h and 24 h after surgery. The incidence of vomiting without nausea, rescue antiemetic use, and the severity of nausea were also evaluated. (3) Results: No significant differences in PONV were identified between the REM and PROP groups at 2 h or 24 h. Furthermore, no differences were observed in any of the measured parameters, and no adverse events were reported. (4) Conclusions: The results of the present study suggest that remimazolam may be as effective as propofol in preventing PONV; however, further investigation is necessary to identify possible differences between these two agents.